A Biotech Founder Makes the Moral Case for Gene-Editing Human Embryos

Origin Genomics founder Cathy Tie called embryo gene editing a “moral imperative” for addressing hereditary diseases, despite the practice remaining controversial and carrying significant risks. The article highlights the tension between potential biotech advances in disease prevention and ethical, safety, and regulatory concerns.